U.S. Army Corps of Engineers Omaha District Monthly Drought Report, September 2006

Current Conditions Drought Outlook Ft. Peck, Montana Reservoir Elevation Overview Water Intake Overview Access Overview Noxious Weeds Overview Cultural Resources Overview Garrison, North Dakota Reservoir Elevation Overview Water Intake Overview Access Overview Boat Ramp Information Noxious Weeds Overview Cultural Resources Overview Other Areas of Interest/Concern Oahe, South Dakota Reservoir Elevation Overview Water Intake Overview Access Overview Noxious Weeds Overview Cultural Resources Overview Mainstem Reservoir Information, Weekly Elevation Comparison 7 AUG 2006 through 28 AUG 2006 Mainstem Reservoir Storage Comparison Water Years 2004, 2005, 2006 Ft. Peck, MT Garrison, ND Oahe, S

Court Review: Volume 39, Issue 3 - Complete Issue

Stadtarchiv Solingen, Bergische Arbeiterstimme 23. September 1915 Werbung für den bergischen Obstmarkt in Leichlingen Leichlingen. Obstmarkt. Man schreibt uns: Unter den im Bergischen lande statfindenden Obstmärkten steht der in diesem Jahre vom 9. bis 11. Oktober dauernde bergische Obstmarkt Leichlingen mit an erster Stelle. Durch seine herrliche Lage und nicht wenig durch seine herrlichen Obstgärten ist Leichlingen bekannt. Im Frühjahr lockt der Blütenflor der Obstbäume viele Tausende..

EC1468 Equipment for Chickens

Extension circular 1468 is about equipment needed to keep poultry feed and water clean

Low-dose lactulose as a prebiotic for improved gut health and enhanced mineral absorption

3openInternationalInternational coauthor/editorAlthough medium and high doses of lactulose are used routinely for the treatment of constipation and hepatic encephalopathy, respectively, a wealth of evidence demonstrates that, at low doses, lactulose can also be used as a prebiotic to stimulate the growth of health-promoting bacteria in the gastrointestinal tract. Indeed, multiple preclinical and clinical studies have shown that low doses of lactulose enhance the proliferation of health-promoting gut bacteria (e.g., Bifidobacterium and Lactobacillus spp.) and increase the production of beneficial metabolites [e.g., short-chain fatty acids (SCFAs)], while inhibiting the growth of potentially pathogenic bacteria (e.g., certain clostridia). SCFAs produced upon microbial fermentation of lactulose, the most abundant of which is acetate, are likely to contribute to immune regulation, which is important not only within the gut itself, but also systemically and for bone health. Low-dose lactulose has also been shown to enhance the absorption of minerals such as calcium and magnesium from the gut, an effect which may have important implications for bone health. This review provides an overview of the preclinical and clinical evidence published to date showing that low-dose lactulose stimulates the growth of health-promoting gut bacteria, inhibits the growth of pathogenic bacteria, increases the production of beneficial metabolites, improves mineral absorption, and has good overall tolerability. Implications of these data for the use of lactulose as a prebiotic are also discussed.openKarakan, Tarkan; Tuohy, Kieran Michael; Janssen-van Solingen, GwendolynKarakan, T.; Tuohy, K.M.; Janssen-van Solingen, G

Differences in In Vitro Properties of Pancreatin Preparations for Pancreatic Exocrine Insufficiency as Marketed in Russia and CIS

BACKGROUND: Pancreatic enzyme-replacement therapy (PERT), provided as pancreatin to patients with pancreatic exocrine insufficiency (PEI), is considered an essential substitute for the pivotal physiological function the pancreas fulfills in digestion. PEI involves a reduction in the synthesis and secretion of pancreatic enzymes (lipase, protease, amylase), which leads to an inadequate enzymatic response to a meal and consequently to maldigestion and malabsorption of nutrients. The efficacy of PERT is strongly dependent on enzyme activity, dissolution, and pancreatin particle size. OBJECTIVE: The physiological properties of eight pancreatin preparations (nine batches; five different brands) available in Russia and CIS (Commonwealth of Independent States: Armenia, Azerbaijan, Belarus, Kazakhstan, Kyrgyzstan, Moldova, Russia, Tajikistan, Uzbekistan) were investigated. METHODS: The lipase activity, dissolution, and particle size distribution of samples from multiple batches of pancreatin of different strengths were measured. RESULTS: Regarding lipase activities, all pancreatin preparations except Micrazim(R) matched the labeled content. Considerable differences were observed in particle size and dissolution. CONCLUSION: Pancreatin preparations available in Russia and CIS demonstrate product-to-product and batch-to-batch variability regarding the measured properties of lipase activity, dissolution, and particle size. This may impact the efficacy of PERT and therefore clinical outcomes